Weak tab. p / o captivity. 5mg

Release form, composition and packaging

?

Pale yellow film-coated tablets, round, biconvex, marked on both sides in the form of a depressed letter S"

in cross section, the core of the tablet is white or almost white.

1 tab.

sodium picosulfate 5 mg

potato starch 27.64 mg, lactose monohydrate 58.45 mg, povidone 2.96 mg, magnesium stearate 0.95 mg.

The composition of the film shell: Opadray II yellow 2.85 mg, including polyvinyl alcohol 1.14 mg, talc 0.422 mg, macrogol 0.576 mg, titanium dioxide 0.695 mg, iron dye yellow oxide 0.017 mg.

10 pieces.

- contoured cell packages (aluminum / PVC) (1) - cardboard packs.

10 pieces.

- contour cell packages (aluminum / PVC) (2) - cardboard packs.

30 pcs.

- polymer cans (1) - cardboard packs.

pharmachologic effect

Laxative.

Under the action of intestinal microorganisms, it is hydrolyzed to form an active form, which irritates the receptors of the intestinal mucosa and increases its peristalsis.

Pharmacokinetics

After oral administration, it is not absorbed from the gastrointestinal tract and does not undergo hepatic-intestinal circulation.

Indications for use

Constipation due to hypotension and sluggish peristalsis of the colon.

Stool regulation for hemorrhoids, proctitis, anal fissures.

Preparation for surgical operations, instrumental and X-ray examinations.

Contraindications for use

Intestinal obstruction, strangulated hernia, acute inflammatory diseases of the abdominal organs, peritonitis, abdominal pain of unknown origin, bleeding from the gastrointestinal tract, uterine bleeding, cystitis, spastic constipation, children under 4 years of age, I trimester of pregnancy, severe dehydration, hypersensitivity to sodium picosulfate.

Dosage regimen

Individual, depending on the patient's age and response to treatment.

It is taken orally before bedtime.

Side effect

Possibly: diarrhea, which can lead to excessive loss of fluid and electrolytes, weakness, seizures, arterial hypotension, and abdominal pain.

Drug interactions

With simultaneous use with broad-spectrum antibiotics, it is possible to reduce the laxative effect of sodium picosulfate.

With simultaneous use with diuretics, with GCS, an increase in the risk of electrolyte disturbances is possible.

The electrolyte imbalance that occurs while taking sodium picosulfate in high doses can lead to a deterioration in the tolerance of cardiac glycosides when used simultaneously.

Application during pregnancy and lactation

Contraindicated in the first trimester of pregnancy.

It should be used in the II and III trimester of pregnancy only if the intended benefit to the mother outweighs the possible risk to the fetus.

If necessary, use during lactation should stop breastfeeding.

Special instructions It has no taste, so children can add to food.

Do not use daily without medical supervision for more than 10 days.

Name ENG

SLABILEN

Clinical and pharmacological group

Laxative drug that stimulates intestinal motility

ATX code

Sodium picosulfate

Dosage

5mg

Structure

...

sodium picosulfate 5 mg.

Excipients: potato starch 27.64 mg, lactose monohydrate 58.45 mg, povidone 2.96 mg, magnesium stearate 0.95 mg.

The composition of the film shell: Opadray II yellow 2.85 mg, including polyvinyl alcohol 1.14 mg, talc 0.422 mg, macrogol 0.576 mg, titanium dioxide 0.695 mg, iron dye yellow oxide 0.017 mg.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

sodium picosulfate

Specifications

Category

Laxatives

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Scope of application

Gastroenterology

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Veropharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Laxative

Anatomical and therapeutic characteristics

A06AB08 Sodium picosulfate

Dosage form

Film-coated tablets

The target audience

Children

Dosage (volume) of the substance in the preparation

sodium picosulfate 5 mg

Expiration date in days

1095

Package weight, g

twenty

Mode of application

:

Individual, depending on the patient's age and response to treatment.

It is taken orally before bedtime.

"